Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose cross-over study of dapagliflozin effects on pancreatic alpha and beta cells in type 2 diabetes
2015-005549-30Phase 4Completed
- Sponsor
- Uppsala University
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dapagliflozin and saxagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Uppsala University. Primary endpoint: Primary. Started Dec 2015; status: completed.
02
Drugs
dapagliflozinsaxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-005549-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005549-30.